Early proliferative response in the human autologous mixed lymphocyte reaction in scleroderma. 1984

J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep

Autologous mixed lymphocyte reaction (AMLR) studied at 7 days with cells from 20 scleroderma patients appeared decreased as compared to healthy matched controls. In kinetic AMLR studies with cells from 16 patients, this was found to result from the decline after an early proliferative response occurring on Day 4 (9 patients) or 5 (4 patients), whereas the other 2 had low responses throughout. As this early response may be anamnestic, kinetic studies lasting 12 days revealed a second proliferative response on the 9th or 10th day and the responses in allogeneic mixed lymphocyte cultures did not differ from those found in normal controls. These findings suggest either that autoreactivity between T and non T cells might have occurred in vivo in scleroderma patients and is recalled in the AMLR or that alterations of immunoregulatory cells permit this earlier activation in the system.

UI MeSH Term Description Entries
D007156 Immunologic Memory The altered state of immunologic responsiveness resulting from initial contact with antigen, which enables the individual to produce antibodies more rapidly and in greater quantity in response to secondary antigenic stimulus. Immune Memory,Immunological Memory,Memory, Immunologic,Immune Memories,Immunologic Memories,Immunological Memories,Memory, Immune,Memory, Immunological
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012595 Scleroderma, Systemic A chronic multi-system disorder of CONNECTIVE TISSUE. It is characterized by SCLEROSIS in the SKIN, the LUNGS, the HEART, the GASTROINTESTINAL TRACT, the KIDNEYS, and the MUSCULOSKELETAL SYSTEM. Other important features include diseased small BLOOD VESSELS and AUTOANTIBODIES. The disorder is named for its most prominent feature (hard skin), and classified into subsets by the extent of skin thickening: LIMITED SCLERODERMA and DIFFUSE SCLERODERMA. Sclerosis, Systemic,Systemic Scleroderma,Systemic Sclerosis

Related Publications

J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
February 1985, Journal of clinical & laboratory immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
January 1983, Journal of clinical immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
July 1982, Gastroenterology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
January 1981, Advances in immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
April 1989, Human immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
December 1981, The Journal of clinical investigation,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
March 1984, Scandinavian journal of immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
March 1980, Journal of immunology (Baltimore, Md. : 1950),
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
May 1985, Journal of clinical immunology,
J Alcocer-Varela, and A Laffón, and D Alarcón-Segovia, and G Ibañez de Kasep
September 1982, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!